PK/PD modeling links accelerated resolution of COVID‐19‐related clinical symptoms to SARS‐CoV‐2 viral load reduction in patients following treatment with Bamlanivimab alone or Bamlanivimab and Etesevimab together

The relationship between severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) viral load reduction and disease symptom resolution remains largely undefined for coronavirus disease 2019 (COVID‐19). While the vaccine‐derived immunity takes time to develop, neutralizing monoclonal antibodies of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ernest, C. Steven, Chien, Jenny Y., Patel, Dipak R., Chigutsa, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111027/
https://www.ncbi.nlm.nih.gov/pubmed/35289125
http://dx.doi.org/10.1002/psp4.12784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111027/
https://www.ncbi.nlm.nih.gov/pubmed/35289125
http://dx.doi.org/10.1002/psp4.12784

Ejemplares similares